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Cell culture from vials usually includes an open phase
performed under laminar flow hoods. Even if disposable
and small closed systems are available, at least the first
cell culture step after vial thawing, which is a centrifuga-
tion, is performed in disposable but open containers.
This step is critical as the risk of contamination is high
and it also has a direct impact on process timelines.
In order to reduce the risk of contamination during
thawing, Merck Serono Biodevelopment studied the pos-
sibility of freezing cell banks in bags and to directly thaw-
ing them directly in disposable and closed containers.
The first step of this study was to evaluate if the
DMSO present in freezing media had to be removed
just after vial thawing or not. In general, this cryopro-
tective organic solvent is removed by centrifugation to
avoid any toxic effect on cells.
So vials from two different mammalian cell lines were
thawed, each with and without a centrifugation step to
remove DMSO, or not. Afterwards the cell amplification
was performed in the same way for the two different thaw-
ing procedures. The population doubling level and the via-
bility were monitored for more than 15 days and there
was no significant impact neither on cell growth nor on
viability whether DMSO was removed or not just after
thawing, or not. The important parameter to take into
account was the percentage of DMSO after dilution which
had to be less than 0,5%.
In order to reduce the risk of preparing cell banks, Merck
Serono Biodevelopment looked at different disposable
closed systems which allow cell banks to be prepared with-
out laminar flow. It is possible to expand cells in closed
containers such as spinners, shake flasks or rollers with
deep tubes in addition to bags or disposable bioreactors. In
order to concentrate cells or to change the medium from
cell amplification to a cell freezing medium a centrifugation
step may be necessary. Single use 500mL centrifuge tubes
with deep tube and air vent are also available. In order to
freeze cells, Merck Serono Biodevelopment evaluated sev-
eral bags from several suppliers and chose the NovaSep-
tum
® 100mL bag and the NovaSeptum
® Case. The
combination of these 2 elements ensured the integrity of
the bag during freezing at -80°C (Figure 1-2).
Thus 50mL of two different concentrated mammalian
cell suspensions were frozen at -80°C and thawed in dispo-
sable and closed containers. The cells were not centrifuged
just after thawing but expanded in order to seed a produc-
tion bioreactor. The cells were also maintained in order to
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Figure 1 NovaSeptum 100mL bag and NovaSeptum case
configurations
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on viability and cell growth. The population doubling
level, the cell viability obtained in disposable closed cell
culture containers in addition to viable cell density, meta-
bolism, molecule quantity and quality obtained in bioreac-
tors were monitored. These parameters were compared to
the same process performed with cells coming from vials.
There was no process performance difference obtained
between cells frozen in bags and cells frozen in vials.
Cell freezing in bags without DMSO removal allows a
fully closed cell culture and production process to be
performed. It also allows process timelines to be
reduced by least 2 weeks.
The study will continue with a focus on bags which
are compatible with nitrogen containers. The quality
aspect will also be studied in order to be able to prepare
a full or part of manufacturing of cell banks in bags.
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Figure 2 NovaSeptum 100mL bag and NovaSeptum case
configurations
Polès-Lahille et al. BMC Proceedings 2011, 5(Suppl 8):P1
http://www.biomedcentral.com/1753-6561/5/S8/P1
Page 2 of 2